Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Clinical RadiologyReferences
- Cancer facts & figures 2018. American Cancer Society website.(Available at:) (Accessed November 30, 2018)
- Cancer statistics, 2018.CA Cancer J Clin. 2018; 68: 7-30
- Reduced lung-cancer mortality with low-dose computed tomographic screening.N Engl J Med. 2011; 365: 395-409
De Koning H, Van Der Aalst C, Ten Haaf K, et al. Effects of volume CT lung cancer screening: Mortality results of the NELSON randomized-controlled population based trial. 2018 World Conference on Lung Cancer. Abstract PL02.05. Toronto, Canada, September 25, 2018.
- Final update summary: lung cancer: screening.(Available at:)https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening(Accessed November 30, 2018)Date: 2015
- Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N).(Available at:) (Accessed November 30, 2018)
- Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.Ann Intern Med. 2015; 162: 485-491
- Performance of ACR Lung-RADS in a clinical CT lung screening program.J Am Coll Radiol. 2016; 13: R25-R29
- Screening for lung cancer: lexicon for communicating with health care providers.AJR Am J Roentgenol. 2018; 210: 473-479
- Lung CT screening reporting and data system (Lung-RADS).(Available at:) (Accessed November 30, 2018)
- Lung-RADS: pushing the limits.Radiographics. 2017; 37: 1975-1993
- Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2014; 160: 330-338
- Pulmonary ground-glass nodules: increase in mass as an early indicator of growth.Radiology. 2010; 255: 199-206
- Observer variability for classification of pulmonary nodules on low-dose CT images and its effect on nodule management.Radiology. 2015; 277: 863-871
- Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017.Radiology. 2017; 284: 228-243
- Lung-RADS category 4X: does it improve prediction of malignancy in subsolid nodules?.Radiology. 2017; 284: 264-271
- Effectiveness of Lung-RADS in reducing false-positive results in a diverse, underserved, urban lung cancer screening cohort.J Am Coll Radiol. 2018; 16: 419-426
- Modified lung-RADS improves performance of screening LDCT in a population with high prevalence of non-smoking-related lung cancer.Acad Radiol. 2018; 25: 1240-1251
- Early Lung Cancer Action Project: overall design and findings from baseline screening.Lancet. 1999; 354: 99-105
- NELSON lung cancer screening study.Cancer Imaging. 2011; 11: S79-S84
- CT screening for lung cancer brings forward early disease. The randomized Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.Thorax. 2012; 67: 296-301
Li C, Guichet P, Cen S, et al. Lung cancer screening in a socioeconomically disadvantaged population: Baseline and 1st Annual Rescreening Results. Radiological Society of North America 2018 Scientific Assembly and Annual Meeting. Chicago IL, November 25 – November 30, 2018. Available at: archive.rsna.org/2018/18016689.html. Accessed December 2, 2018.
Kessler A, Peng R, Mardakhaev E, et al. Performance of the Vancouver Risk Calculator Compared to ACR Lung-RADS in an Urban, diverse clinical lung cancer screening cohort. Radiological Society of North America 2018 Scientific Assembly and annual Meeting. Chicago IL, November 25 – November 30, 2018. Available at: archive.rsna.org/2018/18008738.html. Accessed December 2, 2018.
- Frequency of incidental findings and subsequent evaluation in low-dose computed tomographic scans for lung cancer screening.Ann Am Thorac Soc. 2017; 14: 1450-1456
- Neglectable benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT.Eur Radiol. 2007; 17: 1474-1482
- Assessing the impact of incidental findings in a lung cancer screening study by using low-dose computed tomography.Can Assoc Radiol J. 2011; 62: 141-145
- Extrapulmonary findings and malignancies in participants screened with chest CT in the National Lung Screening Trial.J Am Coll Radiol. 2017; 14: 324-330
- Incidental findings in lung cancer screening: which ones are relevant?.Semin Roentgenol. 2017; 52: 156-160
- Incidental findings on lung cancer screening: significance and management.Semin Ultrasound CT MR. 2018; 39: 273-281
- Clinical implications and added costs of incidental findings in an early detection study of lung cancer by using low-dose spiral computed tomography.Clin Lung Cancer. 2013; 14: 139-148
- Lung cancer screening with CT: Mayo Clinic experience.Radiology. 2003; 226: 756-761
- Extrapulmonary malignancies detected at lung cancer screening.Radiology. 2011; 261: 293-299
- Managing incidental findings on thoracic CT: mediastinal and cardiovascular findings. A white paper of the ACR Incidental Findings Committee.J Am Coll Radiol. 2018; 15: 1087-1096
- An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.Am J Respir Crit Care Med. 2015; 192: 881-891
- Managing incidental thyroid nodules detected on imaging: white paper of the ACR Incidental Thyroid Findings Committee.J Am Coll Radiol. 2015; 12: 143-150
- Managing incidental findings on abdominal and pelvic CT and MRI, Part 2: white paper of the ACR Incidental Findings Committee II on vascular findings.J Am Coll Radiol. 2013; 10: 789-794
- Managing incidental findings on abdominal and pelvic CT and MRI, Part 4: white paper of the ACR Incidental Findings Committee II on gallbladder and biliary findings.J Am Coll Radiol. 2013; 10: 953-956
- Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer.Radiology. 2016; 281: 947-957. 2
- Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.Int J Radiat Oncol Biol Phys. 2012; 83: 972-979
- Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival.Eur Radiol. 2012; 22: 796-802
- Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer.Clin Cancer Res. 2013; 19: 3591-3599
- Radiomics: extracting more information from medical images using advanced feature analysis.Eur J Cancer. 2012; 48: 441-446
- Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.Nat Commun. 2014; 5: 4006
- Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging.Eur J Radiol. 2009; 70: 232-241
- Predicting malignant nodules from screening CTs.J Thorac Oncol. 2016; 11: 2120-2128
Ma J, Wang Q, Ren Y, et al. Automatic lung nodule classification with radiomics approach. Paper presented at: SPIE Medical Imaging 2016: PACS and imaging informatics: next generation and Innovations 2016; San Diego, California, United States, 5 April 2016.
- Characterization of lung nodule malignancy using hybrid shape and appearance features.in: Medical image computing and Computer-Assisted intervention – MICCAI 2016: 19th International Conference, Athens, Greece, October 17–21, 2016, Proceedings, Part I. vol. 9900. Springer International Publishing, Cham (Swizerland)2016: 662-670
- Discovery radiomics for computed tomography cancer detection.arXive. 2015; (arXiv:1509.00117)
- Radiomics analysis of pulmonary nodules in low-dose CT for early detection of lung cancer.Med Phys. 2018; 45: 1537-1549
- Predicting malignant nodules from screening CTs.J Thorac Oncol. 2016; 11: 2045-2047
- Radiomics: the process and the challenges.Magn Reson Imaging. 2012; 30: 1234-1248
- Serum and blood based biomarkers for lung cancer screening: a systematic review.BMC Cancer. 2018; 18: 181
- Screening and early detection efforts in lung cancer.Cancer. 2015; 121: 1347-1356
- Potential biomarkers for lung cancer screening.Transl Lung Cancer Res. 2014; 3: 139-148
- Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers.Lung. 2014; 192: 639-648
- Current and future molecular diagnostics in non-small-cell lung cancer.Expert Rev Mol Diagn. 2015; 15: 1061-1074
- Lung cancer epigenetics: emerging biomarkers.Biomark Med. 2013; 7: 49-58
- Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era.BMC Med. 2013; 11: 168
- The state of molecular biomarkers for the early detection of lung cancer.Cancer Prev Res (Phila). 2012; 5: 992-1006
- EarlyCDT(R)-lung test: improved clinical utility through additional autoantibody assays.Tumour Biol. 2012; 33: 1319-1326
- miR-Test: a blood test for lung cancer early detection.J Natl Cancer Inst. 2015; 107: djv063
- Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.[Erratum appears in J Clin Oncol. 2014 May 10;32(14):1520].J Clin Oncol. 2014; 32: 768-773
Article info
Publication history
Footnotes
Disclosure Statement: No relevant disclosures.